<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="editorial"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1-3.dtd?><?SourceDTD.Version 1.3?><?ConverterInfo.XSLTName jats2jats3.xsl?><?ConverterInfo.Version 1?><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Antibiotics (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Antibiotics (Basel)</journal-id><journal-id journal-id-type="publisher-id">antibiotics</journal-id><journal-title-group><journal-title>Antibiotics</journal-title></journal-title-group><issn pub-type="epub">2079-6382</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">10044893</article-id><article-id pub-id-type="doi">10.3390/antibiotics12030578</article-id><article-id pub-id-type="publisher-id">antibiotics-12-00578</article-id><article-categories><subj-group subj-group-type="heading"><subject>Editorial</subject></subj-group></article-categories><title-group><article-title>Synthetic Biology Facilitates Antimicrobials Discovery</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-3269-9747</contrib-id><name><surname>Bai</surname><given-names>Linquan</given-names></name><xref rid="c1-antibiotics-12-00578" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Deng</surname><given-names>Zixin</given-names></name><xref rid="c1-antibiotics-12-00578" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-4042-2462</contrib-id><name><surname>Tong</surname><given-names>Yaojun</given-names></name><xref rid="c1-antibiotics-12-00578" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-antibiotics-12-00578">State Key Laboratory of Microbial Metabolism, Joint International Research Laboratory of Metabolic and Developmental Sciences, School of Life Sciences and Technology, Shanghai Jiao Tong University, Shanghai 200240, China</aff><author-notes><corresp id="c1-antibiotics-12-00578"><label>*</label>Correspondence: <email>bailq@sjtu.edu.cn</email> (L.B.); <email>zxdeng@sjtu.edu.cn</email> (Z.D.); <email>yaojun.tong@sjtu.edu.cn</email> (Y.T.)</corresp></author-notes><pub-date pub-type="epub"><day>15</day><month>3</month><year>2023</year></pub-date><pub-date pub-type="collection"><month>3</month><year>2023</year></pub-date><volume>12</volume><issue>3</issue><elocation-id>578</elocation-id><history><date date-type="received"><day>20</day><month>2</month><year>2023</year></date><date date-type="accepted"><day>09</day><month>3</month><year>2023</year></date></history><permissions><copyright-statement>&#x000a9; 2023 by the authors.</copyright-statement><copyright-year>2023</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions></article-meta></front><body><p>We are currently facing two big global challenges: antibiotics shortage and multidrug resistance. Since the &#x0201c;Golden Age&#x0201d; of natural products-based antibiotic discovery in the mid-20th century, we have only discovered a very limited number of new antibiotics. This indicates that the traditional antibiotic discovery pipeline is drying up. Moreover, the misuse and overuse of limited classes of antibiotics have caused the emergence and spread of multidrug resistance. Fortunately, the advance of synthetic biology brings us new opportunities for antibiotic discovery. A starting place could be the genomic (gene) and related enzymatic information with the &#x0201c;bottom-up&#x0201d; strategy [<xref rid="B1-antibiotics-12-00578" ref-type="bibr">1</xref>], empowered by &#x0201c;cutting-edge&#x0201d; biotechnology such as CRISPR-based genome editing [<xref rid="B2-antibiotics-12-00578" ref-type="bibr">2</xref>], to facilitate antibiotic discoveries from natural resources.</p><p>Several important studies [<xref rid="B3-antibiotics-12-00578" ref-type="bibr">3</xref>,<xref rid="B4-antibiotics-12-00578" ref-type="bibr">4</xref>,<xref rid="B5-antibiotics-12-00578" ref-type="bibr">5</xref>,<xref rid="B6-antibiotics-12-00578" ref-type="bibr">6</xref>,<xref rid="B7-antibiotics-12-00578" ref-type="bibr">7</xref>] on synthetic biology-assisted antibiotic research have been published recently, and we strongly feel that it is about time to re-attract researchers&#x02019; attention to antibiotic discovery using cutting-edge concepts such as synthetic biology. This idea encourages us to organize this Special Issue on &#x0201c;Synthetic Biology Brings New Opportunity for Antibiotics Discovery&#x0201d;. This Special Issue covers a broad range of antibiotic research, comprising three review articles and seven original research papers.</p><p>In the review article written by Huang and colleagues [<xref rid="B8-antibiotics-12-00578" ref-type="bibr">8</xref>], the biosynthesis and working mechanisms of specific plant-derived antimicrobial agents such as artemisinin, oleanolic acid, berberine, colchicine, and baicalin are summarized and discussed with a goal to provide insights for the future discovery and development of such agents.</p><p>The review by Wang and colleagues [<xref rid="B9-antibiotics-12-00578" ref-type="bibr">9</xref>] summarizes the diverse secondary metabolites that are produced by a popular edible and medicinal mushroom, <italic toggle="yes">Inonotus hispidus.</italic> Its secondary metabolites are mainly polyphenols and triterpenoids, with multiple bioactivities, including anticancer, immunomodulatory, anti-inflammatory, antioxidant, antimicrobial, and enzyme inhibitory activities. <italic toggle="yes">I. hispidus</italic> is a promising source of bioactive compounds, including antibiotics for health promotion and functional food development.</p><p>To address the challenge of the shortage of antifungals, Zhong and colleagues have written a review [<xref rid="B10-antibiotics-12-00578" ref-type="bibr">10</xref>] that focuses on how to use synthetic biology to facilitate the development of novel antifungal drugs that originate from traditional Chinese medicine derived from natural products.</p><p>In the study conducted by Geng and colleagues, the mechanisms of antibiotic resistance and genes associated with antibiotic resistance in <italic toggle="yes">Zymomonas mobilis</italic> are deeply investigated using bioinformatics and CRISPR/Cas12a-based genome-editing technology. Six ampicillin-resistant genes are identified, and their related mutants are constructed. It shows that ZMO0103 is the key to ampicillin resistance in <italic toggle="yes">Z. mobilis</italic> and how other ampicillin-resistant genes may have a synergistic effect [<xref rid="B11-antibiotics-12-00578" ref-type="bibr">11</xref>]. This study could lay the foundation for further studies of other antibiotic resistance mechanisms.</p><p>The research article conducted by Yang and colleagues reports a novel global regulatory protein, SspH, which is widespread in <italic toggle="yes">Streptomyces</italic>, and this was found to play an important role in controlling different types of antibiotic production. This study provides insight into the regulation of antibiotic biosynthesis and the potential targets for future antibiotic discovery and production [<xref rid="B12-antibiotics-12-00578" ref-type="bibr">12</xref>].</p><p>Liu and colleagues, in their research paper, aimed to identify the genes that are involved in the export of the anti-coccidiosis agent salinomycin produced by <italic toggle="yes">Streptomyces albus</italic> BK3-25. By analyzing transcriptomes, eight putative transporter genes were found and proven to positively impact salinomycin exports. The overexpression of these genes will lead to an increase in the titer of salinomycin and improved self-resistance. The study provides a transcriptome-based strategy for improving the titer of salinomycin and identifying transporter genes for other antibiotics [<xref rid="B13-antibiotics-12-00578" ref-type="bibr">13</xref>].</p><p>In their research article, Xue and colleagues found that L-kynurenine (Kyn) is a building block for the biosynthesis of bioactive natural products. They used a genome-mining approach and discovered a biosynthetic gene cluster (BGC) from <italic toggle="yes">Neosartorya pseudofischeri</italic> that can produce pseudofisnins: novel 1-benzazepine-containing compounds. A methyltransferase named PseC was identified as a crucial enzyme in this BGC, catalyzing di-methylation in an amine group [<xref rid="B14-antibiotics-12-00578" ref-type="bibr">14</xref>].</p><p>Using a combinatory strategy of genome-mining and OSMAC (one strain of many compounds), Zhang and colleagues identified two new and seven known cyclodipeptide derivatives from <italic toggle="yes">Streptomyces</italic> sp. 26D9-414. The new compound 2 showed similar cytotoxicity to cisplatin in treating various cancer cells [<xref rid="B15-antibiotics-12-00578" ref-type="bibr">15</xref>], which is promising for further investigations.</p><p>In the study conducted by Al-Thubaiti and colleagues, metal cefotaxime complexes of Ca(II), Cr(III), Zn(II), Cu(II), and Se(VI) were synthesized and characterized. They then investigated the effects of cefotaxime and cefotaxime metal complexes on oxidative stress and their activity against cancer cells (HepG-2) and bacteria (<italic toggle="yes">Bacillus subtilis</italic> and <italic toggle="yes">Escherichia coli</italic>). The results showed that cefotaxime metal complexes with Zn and Se had high antioxidant activity against HepG-2 cells, and they also presented potent antibacterial activities at low concentrations [<xref rid="B16-antibiotics-12-00578" ref-type="bibr">16</xref>].</p><p>El-Megharbel and colleagues, in their research article, investigated the formation of Mg(II), Fe(III), Cu(II), Zn(II), and Se(IV) complexes of the antibiotic ceftriaxone (CFX). Furthermore, they also investigated the effect of CFX and its metal complexes on oxidative stress and tissue injury in rats. It showed that CFX and its metal complexes, especially CFX/Zn, had high antibacterial activity [<xref rid="B17-antibiotics-12-00578" ref-type="bibr">17</xref>].</p><p>I hope that readers find the articles in this Special Issue interesting and inspiring for their own research. Joining together, let us bring society another &#x0201c;Golden Age&#x0201d; of antibiotic discovery!</p></body><back><ack><title>Acknowledgments</title><p>We would like to thank all authors and reviewers, without your contribution, it is impossible to form such an impactful Special Issue. We also sincerely thank the staff from the Editorial Office who provided great assistance.</p></ack><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-antibiotics-12-00578"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tong</surname><given-names>Y.</given-names></name>
<name><surname>Deng</surname><given-names>Z.</given-names></name>
</person-group><article-title>An aurora of natural products-based drug discovery is coming</article-title><source>Synth. Syst. Biotechnol.</source><year>2020</year><volume>5</volume><fpage>92</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1016/j.synbio.2020.05.003</pub-id><?supplied-pmid 32537523?><pub-id pub-id-type="pmid">32537523</pub-id></element-citation></ref><ref id="B2-antibiotics-12-00578"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tong</surname><given-names>Y.</given-names></name>
<name><surname>Weber</surname><given-names>T.</given-names></name>
<name><surname>Lee</surname><given-names>S.Y.</given-names></name>
</person-group><article-title>CRISPR/Cas-based genome engineering in natural product discovery</article-title><source>Nat. Prod. Rep.</source><year>2019</year><volume>36</volume><fpage>1262</fpage><lpage>1280</lpage><pub-id pub-id-type="doi">10.1039/C8NP00089A</pub-id><?supplied-pmid 30548045?><pub-id pub-id-type="pmid">30548045</pub-id></element-citation></ref><ref id="B3-antibiotics-12-00578"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>Z.Q.</given-names></name>
<name><surname>Koirala</surname><given-names>B.</given-names></name>
<name><surname>Hernandez</surname><given-names>Y.</given-names></name>
<name><surname>Zimmerman</surname><given-names>M.</given-names></name>
<name><surname>Park</surname><given-names>S.</given-names></name>
<name><surname>Perlin</surname><given-names>D.S.</given-names></name>
<name><surname>Brady</surname><given-names>S.F.</given-names></name>
</person-group><article-title>A naturally inspired antibiotic to target multidrug-resistant pathogens</article-title><source>Nature</source><year>2022</year><volume>601</volume><fpage>606</fpage><lpage>611</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-04264-x</pub-id><?supplied-pmid 34987225?><pub-id pub-id-type="pmid">34987225</pub-id></element-citation></ref><ref id="B4-antibiotics-12-00578"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>Z.Q.</given-names></name>
<name><surname>Koirala</surname><given-names>B.</given-names></name>
<name><surname>Hernandez</surname><given-names>Y.</given-names></name>
<name><surname>Zimmerman</surname><given-names>M.</given-names></name>
<name><surname>Brady</surname><given-names>S.F.</given-names></name>
</person-group><article-title>Bioinformatic prospecting and synthesis of a bifunctional lipopeptide antibiotic that evades resistance</article-title><source>Science</source><year>2022</year><volume>376</volume><fpage>991</fpage><lpage>996</lpage><pub-id pub-id-type="doi">10.1126/science.abn4213</pub-id><?supplied-pmid 35617397?><pub-id pub-id-type="pmid">35617397</pub-id></element-citation></ref><ref id="B5-antibiotics-12-00578"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mitcheltree</surname><given-names>M.J.</given-names></name>
<name><surname>Pisipati</surname><given-names>A.</given-names></name>
<name><surname>Syroegin</surname><given-names>E.A.</given-names></name>
<name><surname>Silvestre</surname><given-names>K.J.</given-names></name>
<name><surname>Klepacki</surname><given-names>D.</given-names></name>
<name><surname>Mason</surname><given-names>J.D.</given-names></name>
<name><surname>Terwilliger</surname><given-names>D.W.</given-names></name>
<name><surname>Testolin</surname><given-names>G.</given-names></name>
<name><surname>Pote</surname><given-names>A.R.</given-names></name>
<name><surname>Wu</surname><given-names>K.J.Y.</given-names></name>
<etal/>
</person-group><article-title>A synthetic antibiotic class overcoming bacterial multidrug resistance</article-title><source>Nature</source><year>2021</year><volume>599</volume><fpage>507</fpage><lpage>512</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-04045-6</pub-id><?supplied-pmid 34707295?><pub-id pub-id-type="pmid">34707295</pub-id></element-citation></ref><ref id="B6-antibiotics-12-00578"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Durand-Reville</surname><given-names>T.F.</given-names></name>
<name><surname>Miller</surname><given-names>A.A.</given-names></name>
<name><surname>O&#x02019;Donnell</surname><given-names>J.P.</given-names></name>
<name><surname>Wu</surname><given-names>X.Y.</given-names></name>
<name><surname>Sylvester</surname><given-names>M.A.</given-names></name>
<name><surname>Guler</surname><given-names>S.</given-names></name>
<name><surname>Iyer</surname><given-names>R.</given-names></name>
<name><surname>Shapiro</surname><given-names>A.B.</given-names></name>
<name><surname>Carter</surname><given-names>N.M.</given-names></name>
<name><surname>Velez-Vega</surname><given-names>C.</given-names></name>
<etal/>
</person-group><article-title>Rational design of a new antibiotic class for drug-resistant infections</article-title><source>Nature</source><year>2021</year><volume>597</volume><fpage>698</fpage><lpage>702</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03899-0</pub-id><?supplied-pmid 34526714?><pub-id pub-id-type="pmid">34526714</pub-id></element-citation></ref><ref id="B7-antibiotics-12-00578"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Imai</surname><given-names>Y.</given-names></name>
<name><surname>Meyer</surname><given-names>K.J.</given-names></name>
<name><surname>Iinishi</surname><given-names>A.</given-names></name>
<name><surname>Favre-Godal</surname><given-names>Q.</given-names></name>
<name><surname>Green</surname><given-names>R.</given-names></name>
<name><surname>Manuse</surname><given-names>S.</given-names></name>
<name><surname>Caboni</surname><given-names>M.</given-names></name>
<name><surname>Mori</surname><given-names>M.</given-names></name>
<name><surname>Niles</surname><given-names>S.</given-names></name>
<name><surname>Ghiglieri</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>A new antibiotic selectively kills Gram-negative pathogens</article-title><source>Nature</source><year>2019</year><volume>576</volume><fpage>459</fpage><lpage>464</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1791-1</pub-id><?supplied-pmid 31747680?><pub-id pub-id-type="pmid">31747680</pub-id></element-citation></ref><ref id="B8-antibiotics-12-00578"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Huang</surname><given-names>W.Q.</given-names></name>
<name><surname>Wang</surname><given-names>Y.X.</given-names></name>
<name><surname>Tian</surname><given-names>W.S.</given-names></name>
<name><surname>Cui</surname><given-names>X.X.</given-names></name>
<name><surname>Tu</surname><given-names>P.F.</given-names></name>
<name><surname>Li</surname><given-names>J.</given-names></name>
<name><surname>Shi</surname><given-names>S.P.</given-names></name>
<name><surname>Liu</surname><given-names>X.</given-names></name>
</person-group><article-title>Biosynthesis investigations of terpenoid, alkaloid, and flavonoid antimicrobial agents derived from medicinal plants</article-title><source>Antibiotics</source><year>2022</year><volume>11</volume><elocation-id>1380</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics11101380</pub-id><?supplied-pmid 36290037?><pub-id pub-id-type="pmid">36290037</pub-id></element-citation></ref><ref id="B9-antibiotics-12-00578"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>Z.X.</given-names></name>
<name><surname>Feng</surname><given-names>X.L.</given-names></name>
<name><surname>Liu</surname><given-names>C.W.</given-names></name>
<name><surname>Gao</surname><given-names>J.M.</given-names></name>
<name><surname>Qi</surname><given-names>J.Z.</given-names></name>
</person-group><article-title>Diverse metabolites and pharmacological effects from the Basidiomycetes <italic toggle="yes">Inonotus hispidus</italic></article-title><source>Antibiotics</source><year>2022</year><volume>11</volume><elocation-id>1097</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics11081097</pub-id><?supplied-pmid 36009965?><pub-id pub-id-type="pmid">36009965</pub-id></element-citation></ref><ref id="B10-antibiotics-12-00578"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhong</surname><given-names>H.</given-names></name>
<name><surname>Han</surname><given-names>L.</given-names></name>
<name><surname>Lu</surname><given-names>R.Y.</given-names></name>
<name><surname>Wang</surname><given-names>Y.</given-names></name>
</person-group><article-title>Antifungal and immunomodulatory ingredients from traditional Chinese medicine</article-title><source>Antibiotics</source><year>2023</year><volume>12</volume><elocation-id>48</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics12010048</pub-id><?supplied-pmid 36671249?><pub-id pub-id-type="pmid">36671249</pub-id></element-citation></ref><ref id="B11-antibiotics-12-00578"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Geng</surname><given-names>B.N.</given-names></name>
<name><surname>Huang</surname><given-names>X.Y.</given-names></name>
<name><surname>Wu</surname><given-names>Y.L.</given-names></name>
<name><surname>He</surname><given-names>Q.N.</given-names></name>
<name><surname>Yang</surname><given-names>S.H.</given-names></name>
</person-group><article-title>Identification and characterization of genes related to ampicillin antibiotic resistance in <italic toggle="yes">Zymomonas mobilis</italic></article-title><source>Antibiotics</source><year>2022</year><volume>11</volume><elocation-id>1476</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics11111476</pub-id><?supplied-pmid 36358131?><pub-id pub-id-type="pmid">36358131</pub-id></element-citation></ref><ref id="B12-antibiotics-12-00578"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yang</surname><given-names>X.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.Y.</given-names></name>
<name><surname>Li</surname><given-names>S.S.</given-names></name>
<name><surname>Ye</surname><given-names>L.</given-names></name>
<name><surname>Wang</surname><given-names>X.J.</given-names></name>
<name><surname>Xiang</surname><given-names>W.S.</given-names></name>
</person-group><article-title>SspH, a novel HATPase family regulator, controls antibiotic biosynthesis in <italic toggle="yes">Streptomyces</italic></article-title><source>Antibiotics</source><year>2022</year><volume>11</volume><elocation-id>538</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics11050538</pub-id><?supplied-pmid 35625182?><pub-id pub-id-type="pmid">35625182</pub-id></element-citation></ref><ref id="B13-antibiotics-12-00578"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>X.</given-names></name>
<name><surname>Wu</surname><given-names>Y.T.</given-names></name>
<name><surname>Zhang</surname><given-names>X.J.</given-names></name>
<name><surname>Kang</surname><given-names>Q.J.</given-names></name>
<name><surname>Yan</surname><given-names>Y.S.</given-names></name>
<name><surname>Bai</surname><given-names>L.Q.</given-names></name>
</person-group><article-title>Comparative transcriptome-based mining of genes involved in the export of polyether antibiotics for titer improvement</article-title><source>Antibiotics</source><year>2022</year><volume>11</volume><elocation-id>600</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics11050600</pub-id><?supplied-pmid 35625244?><pub-id pub-id-type="pmid">35625244</pub-id></element-citation></ref><ref id="B14-antibiotics-12-00578"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xue</surname><given-names>X.X.</given-names></name>
<name><surname>Chen</surname><given-names>L.</given-names></name>
<name><surname>Tang</surname><given-names>M.C.</given-names></name>
</person-group><article-title>Genome mining discovery of a new benzazepine alkaloid pseudofisnin A from the marine fungus <italic toggle="yes">Neosartorya pseudofischeri</italic> F27-1</article-title><source>Antibiotics</source><year>2022</year><volume>11</volume><elocation-id>1444</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics11101444</pub-id><?supplied-pmid 36290102?><pub-id pub-id-type="pmid">36290102</pub-id></element-citation></ref><ref id="B15-antibiotics-12-00578"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>D.S.</given-names></name>
<name><surname>Wang</surname><given-names>J.B.</given-names></name>
<name><surname>Qiao</surname><given-names>Y.J.</given-names></name>
<name><surname>Lin</surname><given-names>B.X.</given-names></name>
<name><surname>Deng</surname><given-names>Z.X.</given-names></name>
<name><surname>Kong</surname><given-names>L.X.</given-names></name>
<name><surname>You</surname><given-names>D.L.</given-names></name>
</person-group><article-title>Genome mining and metabolic profiling reveal cytotoxic cyclodipeptides in <italic toggle="yes">Streptomyces hygrospinosus</italic> var. Beijingensis</article-title><source>Antibiotics</source><year>2022</year><volume>11</volume><elocation-id>1463</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics11111463</pub-id><?supplied-pmid 36358118?><pub-id pub-id-type="pmid">36358118</pub-id></element-citation></ref><ref id="B16-antibiotics-12-00578"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Al-Thubaiti</surname><given-names>E.H.</given-names></name>
<name><surname>El-Megharbel</surname><given-names>S.M.</given-names></name>
<name><surname>Albogami</surname><given-names>B.</given-names></name>
<name><surname>Hamza</surname><given-names>R.Z.</given-names></name>
</person-group><article-title>Synthesis, spectroscopic, chemical characterizations, anticancer capacities against HepG-2, antibacterial and antioxidant activities of cefotaxime metal complexes with Ca(II), Cr(III), Zn(II), Cu(II) and Se(IV)</article-title><source>Antibiotics</source><year>2022</year><volume>11</volume><elocation-id>967</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics11070967</pub-id><?supplied-pmid 35884222?><pub-id pub-id-type="pmid">35884222</pub-id></element-citation></ref><ref id="B17-antibiotics-12-00578"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>El-Megharbel</surname><given-names>S.M.</given-names></name>
<name><surname>Qahl</surname><given-names>S.H.</given-names></name>
<name><surname>Alaryani</surname><given-names>F.S.</given-names></name>
<name><surname>Hamza</surname><given-names>R.Z.</given-names></name>
</person-group><article-title>Synthesis, spectroscopic studies for five new Mg (II), Fe (III), Cu (II), Zn (II) and Se (IV) ceftriaxone antibiotic drug complexes and their possible hepatoprotective and antioxidant capacities</article-title><source>Antibiotics</source><year>2022</year><volume>11</volume><elocation-id>547</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics11050547</pub-id><?supplied-pmid 35625191?><pub-id pub-id-type="pmid">35625191</pub-id></element-citation></ref></ref-list></back></article>